Functional Genomics Conference: From Identifying Proteins to Faster Drug Discovery. March 10-11, 1998, Washington DC,...

Area of Science:

• Genomics and Bioinformatics
• Drug Discovery and Development
• Functional Genomics

Background:

• Extensive genome sequencing efforts have generated a large volume of data for various organisms, including humans.
• Despite the abundance of sequence data, the functional roles of most genes remain unknown, limiting their utility as drug targets.
• Functional genomics, or high-throughput biology, emerged to address the challenge of understanding gene function and identifying potential therapeutic targets.

Purpose of the Study:

• To explore the application of functional genomics in accelerating drug discovery.
• To highlight advancements in technologies for identifying and validating drug targets from genomic data.
• To discuss the integration of various technologies in the modern drug discovery process.

Main Methods:

• Utilizing high-throughput biology approaches to study gene function.
• Employing comparative genomics by studying conserved genes in simpler organisms.
• Leveraging technologies such as gene chips, bioinformatics, and protein discovery platforms.

Main Results:

• Functional genomics enables the transition from raw sequence data to actionable information for drug target identification.
• High-throughput tools and integrated approaches are crucial for genome-based drug discovery.
• Studying gene function in model organisms can provide insights applicable to human therapeutics.

Conclusions:

• Functional genomics is essential for unlocking the therapeutic potential of genomic data.
• Advancements in high-throughput technologies are critical for efficient drug discovery.
• Integrating diverse technologies is key to navigating the complexities of modern drug development.